BrianICarrMDFRCP, PhD

Oncology • Philadelphia, PA

Gastrointestinal Cancer

Physician

Join to view full profile

Dr. Carr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Carr's full profile

Already have an account?

Office
Kimmel Cancer Center. 111 S 11th St
Suite 4240
Philadelphia, PA 19107
Phone+1 412-980-4518

Fax+1 215-955-2340

Summary

Specialist in primary tumors of the liver-HCC, CCC and NET

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1977 - 1979
University of LondonMD, Medicine, 1964 - 1967
Imperial College London School of MedicineClass of 1967, PhD

Certifications & Licensure

PA State Medical License 1989 - 2024
CA State Medical License 1979 - 2019
WI State Medical License 1979 - 2015

Clinical Trials

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Feb 01
Completed
Phase 3

Publications & Presentations

PubMed

26 citations
Sorafenib combined vitamin k induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways
Gang Wei, Meifang Wang, Brian I. Carr
Journal of Cellular Physiology. 2010-07-01
45 citations
Vitamin K enhancement of sorafenib‐mediated HCC cell growth inhibition in vitro and in vivo
Gang Wei, Meifang Wang, Terry Hyslop, Ziqiu Wang, Brian I. Carr
International Journal of Cancer. 2010-12-15
13 citations
Reversibility of regorafenib effects in hepatocellular carcinoma cells
Rosalba D'Alessandro, Maria Grazia Refolo, Catia Lippolis, Caterina Messa, Aldo Cavallini
Cancer Chemotherapy and Pharmacology. 2013-08-20

Grant Support

K Vitamins- A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2007–2008
K Vitamins- A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2004–2006
K Vitamins--A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2000–2003
Prognostic Factors In Human HepatomaNational Cancer Institute1992
TGFB Receptors In HepatocarcinogenesisNational Cancer Institute1989–1992
TGFB Receptors In HepatocarcinogenesisNational Cancer Institute1988–1989

Professional Memberships

Other Languages

French, Italian, Hebrew